Use of complementary and alternative medicine among females with polycystic ovary syndrome in Jordan: a cross-sectional study

Use of complementary and alternative medicine among females with polycystic ovary syndrome in Jordan: a cross-sectional study

Background and objectives Polycystic ovary syndrome (PCOS) is a prevalent female reproductive and metabolic disorder. Among patients with chronic conditions, an increasing number have approached complementary and alternative medicine (CAM) to cope with their disease. This study aimed to assess the u...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Oriana Awwad, Mais Saleh, Ali Alsamydai, Fatma U Afifi, Amal Akour, Renad Abu Tarboosh, Manar Hamdan, Asma Sa’d Basha, Sanaa K Bardaweel
Format:	Artykuł
Język:	English
Wydane:	BMJ Publishing Group 2024-12-01
Seria:	BMJ Open
Dostęp online:	https://bmjopen.bmj.com/content/14/12/e088945.full

Podobne zapisy

Markers of hyperandrogenism in South Asians with polycystic ovary syndrome
od: WMM Boteju, i wsp.
Wydane: (2014-08-01)

Polycystic Ovary Syndrome
od: Yong-Il Ji, i wsp.
Wydane: (2015-12-01)

Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndrome
od: Nearmeen M. Rashad, i wsp.
Wydane: (2017-09-01)

Rethinking the Terminology: A Perspective on Renaming Polycystic Ovary Syndrome for an Enhanced Pathophysiological Understanding
od: Ach Taieb, i wsp.
Wydane: (2024-10-01)

Effect of Polycystic Ovaries on the Morphology of Uterus and Ovaries
od: Ambreen Usmani, i wsp.
Wydane: (2024-05-01)

Use of traditional and complementary medicine by ethnic Indian women living with polycystic ovary syndrome: a global survey
od: Vibhuti Samarth Rao, i wsp.
Wydane: (2023-11-01)

Anti-Mullarian Hormone As A Diagnostic Marker of Polycystic Ovary Syndrome
od: Shabana Abbas, i wsp.
Wydane: (2024-02-01)

Obesity and polycystic ovary syndrome.
od: Barber, T, i wsp.
Wydane: (2006)

Obesity and Polycystic Ovary Syndrome
od: Jin Ju Kim
Wydane: (2024-12-01)

hyperandrogenism in polycystic ovary syndrome
od: malka S. Al- saadi
Wydane: (2006-01-01)

Quercetin and polycystic ovary syndrome
od: Congshun Ma, i wsp.
Wydane: (2022-12-01)

Polycystic Ovary Syndrome in Adolescence
od: Rebecca Deans
Wydane: (2019-10-01)

On the therapy for polycystic ovary syndrome
od: Vittorio Unfer, i wsp.
Wydane: (2017-01-01)

Pregnancy in polycystic ovary syndrome
od: Sadishkumar Kamalanathan, i wsp.
Wydane: (2013-01-01)

Kisspeptin and Polycystic Ovary Syndrome
od: Rong Tang, i wsp.
Wydane: (2019-05-01)

The inositols and polycystic ovary syndrome
od: Bharti Kalra, i wsp.
Wydane: (2016-01-01)

Polycystic Ovary Syndrome in University Students: Occurrence and Associated Factors
od: Amita Attlee, i wsp.
Wydane: (2014-10-01)

The Relationship of Staphylococcus aureus Virulancity with Serum Cytokine Levels in Polycystic Ovary Syndrome and Polycystic Ovary Disease
od: AL-Khafaji Rana Jaleil, i wsp.
Wydane: (2024-01-01)

Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
od: Xu Boqun, i wsp.
Wydane: (2013-01-01)

Metabolic syndrome in polycystic ovary syndrome.
od: Barber, T, i wsp.
Wydane: (2007)

Secondary forms of polycystic ovary syndrome.
od: Kaltsas, G, i wsp.
Wydane: (2004)

The prevalence of polycystic ovaries in infertility by laparoscopy ‎
od: Tahereh Ziaie, i wsp.
Wydane: (2013-09-01)

Diagnosis and treatment of polycystic ovary syndrome
od: Ronelsys Martínez Martínez, i wsp.
Wydane: (2023-11-01)

From the history of polycystic ovary syndrome
od: D. A. Kiryushkina
Wydane: (2019-09-01)

Valproate Induced Obesity and Polycystic Ovaries
od: J Gordon Millichap
Wydane: (1996-06-01)

Valproate, Menstrual Disorder and Polycystic Ovaries
od: J Gordon Millichap
Wydane: (2000-08-01)

Immunophenotypic Profiles in Polycystic Ovary Syndrome
od: Cong Hu, i wsp.
Wydane: (2020-01-01)

Infertility treatment in Polycystic Ovary Syndrome
od: Thanyarat Wongwananuruk
Wydane: (2009-03-01)

Role of Metformin in Polycystic Ovary Syndrome
od: Karolina Nowak, i wsp.
Wydane: (2024-01-01)

Reconsidering the Polycystic Ovary Syndrome (PCOS)
od: Norbert Gleicher, i wsp.
Wydane: (2022-06-01)

Estrogen Receptors in Polycystic Ovary Syndrome
od: Xue-Ling Xu, i wsp.
Wydane: (2021-02-01)

The role of the thyroid in polycystic ovary syndrome
od: Huanhuan Fan, i wsp.
Wydane: (2023-10-01)

Editorial: Epigenetics of polycystic ovary syndrome
od: Jim Parker, i wsp.
Wydane: (2023-09-01)

The Psychosocial Impact of Polycystic Ovary Syndrome
od: Virginie Simon, i wsp.
Wydane: (2023-03-01)

POLYCYSTIC OVARY SYNDROME, LACTOGENESIS AND BREASTFEEDING
od: Irena Hren, i wsp.
Wydane: (2023-04-01)

Berberine in the treatment of polycystic ovary syndrome
od: Łukasz Ochyra, i wsp.
Wydane: (2022-04-01)

Vitamin D and polycystic ovary syndrome
od: Wen-Ling Lee, i wsp.
Wydane: (2022-11-01)

Polycystic ovary syndrome and pregnancy - review
od: Magdalena Grześk-Kaczyńska, i wsp.
Wydane: (2022-06-01)

AMORPHOPHALLUS KONJAC AND POLYCYSTIC OVARY SYNDROME
od: Ehab Hussein, i wsp.
Wydane: (2020-06-01)

Polycystic ovaries and infertility: Our experience
od: Lavanya Rajashekar, i wsp.
Wydane: (2008-01-01)